Next Quarterly Earnings
Tuesday, March 23, 2027
Expected
Newron Pharmaceuticals is a research-driven biopharmaceutical company based in Italy. It specializes in the development of innovative therapies for diseases of the central nervous system, focusing on novel medications for the treatment of various neurological and psychiatric conditions.
Newron Pharmaceuticals last reported quarterly earnings on 9/22/2026 (Q2 2026). Earnings per share (EPS) came in at -0.74 CHF.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.